Corcept Therapeutics (NASDAQ:CORT) Price Target Raised to $150.00
Corcept Therapeutics (NASDAQ:CORT – Get Free Report) had its price target hoisted by stock analysts at HC Wainwright from $115.00 to $150.00 in a research note issued on Monday,Benzinga reports. The firm currently has a “buy” rating on the biotechnology company’s stock. HC Wainwright’s price objective points to a potential upside of 63.17% from the […]
Corcept Therapeutics (NASDAQ:CORT – Get Free Report) had its price target hoisted by stock analysts at HC Wainwright from $115.00 to $150.00 in a research note issued on Monday,Benzinga reports. The firm currently has a “buy” rating on the biotechnology company’s stock. HC Wainwright’s price objective points to a potential upside of 63.17% from the […]
